BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-247@pharmaconomics
DTSTAMP:20260707T020518Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:NUVL Catalyst — zidesamtinib (estimated date)
DESCRIPTION:A key catalyst for zidesamtinib (ROS1-positive NSCLC) is expected ~ Dec 31\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1861560/000119312526012243/nuvl-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/247
URL:https://pharmaconomics.com/e/247
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:NUVL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR